<SEC-DOCUMENT>0000200406-17-000055.txt : 20171221
<SEC-HEADER>0000200406-17-000055.hdr.sgml : 20171221
<ACCEPTANCE-DATETIME>20171221172943
ACCESSION NUMBER:		0000200406-17-000055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171221
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171221
DATE AS OF CHANGE:		20171221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		171270370

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a20171221form8-kjanssenand.htm
<DESCRIPTION>8-K JANSSEN TIEGEN
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sa72e331ed574421d978b29b27d93b2c1"></a></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;text-align:right;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;"><hr></div><div style="line-height:174%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, DC 20549</font></div><div style="line-height:174%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities Exchange Act of 1934</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of report (Date of earliest event reported):&#160;&#160;December 21, 2017</font></div><div style="line-height:174%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;"><hr></div><div style="line-height:174%;text-align:center;-sec-extract:summary;"><img src="jnjlogorgb4a08.jpg" alt="jnjlogorgb4a08.jpg" style="height:72px;width:236px;"></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:36%;"></td><td style="width:35%;"></td><td style="width:29%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New Jersey</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I-3215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22-1024240</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer Identification No.)</font></div></td></tr></table></div></div><div style="line-height:174%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One Johnson &amp; Johnson Plaza, New Brunswick, New Jersey&#160;08933</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices) (Zip Code)</font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code:&#160;&#160;732-524-0400</font></div><div style="line-height:174%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:174%;text-align:left;text-indent:48px;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div><div style="line-height:174%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company    </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><hr></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;-sec-extract:summary;"><hr></div><div style="line-height:232%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01  Other Events.</font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Janssen Biotech, Inc. (&#8220;Janssen&#8221;), a Janssen Pharmaceutical Company of Johnson &amp; Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited (&#8220;Legend&#8221;), subsidiaries of Genscript Biotech Corporation, to develop, manufacture and commercialize a chimeric antigen receptor (CAR) T-cell drug candidate, LCAR-B38M, which specifically targets the B-cell maturation antigen (BCMA). LCAR-B38M is currently accepted for review by the China Food and Drug Administration (CFDA) and in the planning phase of clinical studies in the United States for multiple myeloma. </font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LCAR-B38M is the first CAR-T therapy accepted for review by the CFDA. Under terms of the agreement, Legend will grant Janssen a worldwide license to jointly develop and commercialize LCAR-B38M in multiple myeloma with the Legend team of experts. Janssen will record worldwide net trade sales, except for sales made in Greater China. The companies have entered into a 50/50 percent cost-sharing/profit-split arrangement, except in Greater China, where Janssen and Legend have a 30/70 percent cost-sharing/profit-split arrangement. Janssen will make an upfront payment&#160;of $350 million that will be recorded in the fourth quarter and additional payments based upon the achievement of certain development, regulatory and sales milestones. </font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson reaffirms its previously announced adjusted earnings guidance for full-year 2017 of $7.25-$7.30 per share.</font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The press release dated December 21, 2017 is attached as Exhibit 99.1 to this Report.</font></div><div style="line-height:174%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Exhibits</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit No.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:78.3203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:22%;"></td><td style="width:78%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="janssenteigenpressrelease_.htm"><font style="font-family:inherit;font-size:10pt;">Press release dated December 21, 2017.</font></a></div></td></tr></table></div></div><div style="line-height:174%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:174%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:47%;"></td><td style="width:7%;"></td><td style="width:33%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Johnson &amp; Johnson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;(Registrant)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;&#160;December 21, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/S/ Thomas J. Spellman III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thomas J. Spellman III</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assistant General Counsel and</font></div><div style="padding-bottom:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate Secretary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>janssenteigenpressrelease_.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s423224E5A3D99A0B57917A306CE6CB1A"></a></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></div><div><br></div><div style="line-height:120%;text-align:right;padding-left:432px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;padding-left:432px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:432px;"><img src="janssenteigenpressrel_image1.gif" alt="janssenteigenpressrel_image1.gif" style="height:66px;width:156px;"></div><div style="line-height:120%;text-align:left;padding-left:432px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.58974358974359%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:20%;"></td><td style="width:28%;"></td><td style="width:26%;"></td><td style="width:26%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Media Inquiries:</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Satu Kaarina Glawe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Linda Davis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ying Du</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(U.S. and Europe)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(U.S.)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(China)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mobile:  +49-172-294-6264</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mobile:  1-215-272-8787</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Phone: +86-10-58218323</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Relations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Joseph J. Wolk</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lesley Fishman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Johnson &amp; Johnson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Phone:  1-732-524-1142</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Phone:  1-732-524-3922</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:432px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Janssen Enters Worldwide Collaboration and License Agreement with </font></div><div style="line-height:180%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy</font></div><div style="line-height:180%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">CAR-T BCMA in Development for Patients with Multiple Myeloma </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">HORSHAM, PA (December 21, 2017) &#8211; Janssen Biotech, Inc. (&#8220;Janssen&#8221;), a Janssen Pharmaceutical Company of Johnson &amp; Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited (&#8220;Legend&#8221;), subsidiaries of Genscript Biotech Corporation, to develop, manufacture and commercialize a chimeric antigen receptor (CAR) T-cell drug candidate, LCAR-B38M, which specifically targets the B-cell maturation antigen (BCMA). LCAR-B38M is currently accepted for review by the China Food and Drug Administration (CFDA) and in the planning phase of clinical studies in the United States for multiple myeloma. </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8220;Despite significant advances, multiple myeloma remains an incurable disease for most patients, creating the need for additional, highly active options. LCAR-B38M provides an innovative approach with the potential to transform the treatment of myeloma,&#8221; said Peter F. Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research &amp; Development, LLC. &#8220;We look forward to collaborating with the pioneering scientific team at Legend and applying our expertise to the development of this cell therapy, with the goal of building regimens aiming for a cure.&#8221;</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">LCAR-B38M is the first CAR-T therapy accepted for review by the CFDA. Under terms of the agreement, Legend will grant Janssen a worldwide license to jointly develop and commercialize LCAR-B38M in </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></div><div><br></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">multiple myeloma with the Legend team of experts. Janssen will record worldwide net trade sales, except for sales made in Greater China. The companies have entered into a 50/50 percent cost-sharing/profit-split arrangement, except in Greater China, where Janssen and Legend have a 30/70 percent cost-sharing/profit-split arrangement. Janssen will make an upfront payment&#160;of $350 million that will be recorded in the fourth quarter and additional payments based upon the achievement of certain development, regulatory and sales milestones. </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Johnson &amp; Johnson reaffirms its previously announced adjusted earnings guidance for full-year 2017 of $7.25-$7.30 per share.</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8220;We are pleased to enter into a partnership with Legend to gain access to their CAR-T platform, an important future therapeutic modality for Janssen,&#8221; says Mathai Mammen, M.D., Ph.D., Global Head, Science &amp; Development, Janssen Research &amp; Development, LLC. &#8220;Legend is an innovative biotech company that has developed a differentiated CAR-T therapy, which has shown promising results in early-stage multiple myeloma trials conducted in China. We are excited to bring Janssen&#8217;s global expertise in drug development to advance this innovation into potential new treatment options for patients around the world.&#8221; </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About CAR-T and BCMA</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">CAR T-cells are an innovative approach to eradicate cancer cells by harnessing the power of a patient&#8217;s own immune system. BCMA is a protein that is highly expressed on myeloma cells. By targeting BCMA via a CAR-T approach, CAR-T therapies may have the potential to redefine the treatment paradigm for multiple myeloma and potentially advance towards cures for patients with the disease. </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About Multiple Myeloma</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Multiple myeloma is an incurable blood cancer that occurs when malignant plasma cells grow uncontrollably in the bone marrow.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1,2</sup></font><font style="font-family:Arial;font-size:10pt;">&#32;While some patients with myeloma have no symptoms at all, most patients are diagnosed due to symptoms, which can include bone fracture or pain, low red blood counts, fatigue, calcium elevation, kidney problems or infections.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">3</sup></font><font style="font-family:Arial;font-size:10pt;">&#32;Despite significant treatment advances in the past 10 years, many myeloma patients relapse after initial or secondary treatment and/or become resistant to therapies. There is a significant unmet medical need for more efficacious treatments that can overcome resistance associated with standard of care based on an immunomodulatory agent and/or a proteasome inhibitor to induce deeper and durable responses.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1,4 </sup></font><font style="font-family:Arial;font-size:10pt;">Globally, it is estimated that 124,225 people were diagnosed and 87,084 died from multiple myeloma in 2015.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">5,6</sup>&#160;</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></div><div><br></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Janssen in Oncology </font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In oncology, our goal is to fundamentally alter the way cancer is understood, diagnosed and managed, reinforcing our commitment to the patients who inspire us. In looking to find innovative ways to address the cancer challenge, our primary efforts focus on several treatment and prevention solutions. These include a focus on hematologic malignancies, prostate cancer and lung cancer; cancer interception with the goal of developing products that interrupt the carcinogenic process; biomarkers that may help guide targeted, individualized use of our therapies; as well as safe and effective identification and treatment of early changes in the tumor microenvironment. Please visit www.janssen.com/oncology.</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About the Janssen Pharmaceutical Companies</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenUS and www.twitter.com/JanssenGlobal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About Johnson &amp; Johnson</font><font style="font-family:Arial;font-size:10pt;">&#32;<br>Caring for the world, one person at a time, inspires and unites the people of Johnson &amp; Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 134,100 employees at more than 250 Johnson &amp; Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"># # #</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Cautions Concerning Forward-Looking Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 related to a new collaboration and product development. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Janssen Biotech, Inc. and/or Johnson &amp; Johnson. Risks and uncertainties include, but are not limited to: the potential that the expected benefits and opportunities related to the collaboration may not be realized or may take longer to realize than expected; challenges inherent in new product development, including the uncertainty of clinical success and obtaining regulatory approvals; competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></div><div><br></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">products; the ability of the company and Legend to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson &amp; Johnson's Annual Report on Form 10-K for the fiscal year ended January 1, 2017, including under &#8220;Item 1A. Risk Factors,&#8221; its most recently filed Quarterly Report on Form 10-Q, including under the caption &#8220;Cautionary Note Regarding Forward-Looking Statements,&#8221; and the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson &amp; Johnson. The Janssen Pharmaceutical Companies of Johnson &amp; Johnson and Johnson &amp; Johnson do not undertake to update any forward-looking statement as a result of new information or future events or developments.</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">_______________</font></div><div style="line-height:180%;text-align:center;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:Arial;font-size:8pt;">Kumar, SK et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. </font><font style="font-family:Arial;font-size:8pt;font-style:italic;">Leukemia</font><font style="font-family:Arial;font-size:8pt;">. 2012;26(1):149-157. https://www.ncbi.nlm.nih.gov/pubmed/21799510. </font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup></font><font style="font-family:Arial;font-size:8pt;">American Cancer Society. "Multiple Myeloma Overview." Available at: http://www.cancer.org/cancer/multiplemyeloma/detailedguide/multiple-myeloma-what-is-multiple-myeloma. Accessed December 2017.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">3</sup></font><font style="font-family:Arial;font-size:8pt;">American Cancer Society. "How is Multiple Myeloma Diagnosed?" Available at: http://www.cancer.org/cancer/multiplemyeloma/detailedguide/multiple-myeloma-diagnosis. Accessed December 2017.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></font><font style="font-family:Arial;font-size:8pt;">Borrello, I. Can we change the disease biology of multiple myeloma? </font><font style="font-family:Arial;font-size:8pt;font-style:italic;">Leukemia </font><font style="font-family:Arial;font-size:8pt;">Research. 2012;36(0 1):S3-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698609/.</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">&#160;</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">5</sup></font><font style="font-family:Arial;font-size:8pt;">GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide: Number of New Cancers in 2015. Available at: http://globocan.iarc.fr/old/burden.asp?selection_pop=224900&amp;Text-p=World&amp;selection_cancer=17270&amp;Text-c=Multiple+myeloma&amp;pYear=3&amp;type=0&amp;window=1&amp;submit=%C2%A0Execute. Accessed December 2017.</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">6</sup></font><font style="font-family:Arial;font-size:8pt;">GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide: Number of Cancer Deaths in 2015. Available at: http://globocan.iarc.fr/old/burden.asp?selection_pop=224900&amp;Text-p=World&amp;selection_cancer=17270&amp;Text-c=Multiple+myeloma&amp;pYear=3&amp;type=1&amp;window=1&amp;submit=%C2%A0Execute. Accessed December 2017.</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></td></tr></table></div></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>janssenteigenpressrel_image1.gif
<TEXT>
begin 644 janssenteigenpressrel_image1.gif
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M.Z32!AI XA+O\Q_QD,4/ (HQ)U2#(OU 1R%6?%!ZSH 0&IN(/EC1 0H:X ?
M./$_U.$$AVIG W^0Z$/B 8A<(I0'NECJ0^CABRAXP,C?4H(PA-R4+702M_A[
MP&Y+(LH!U!%?!N!!(8C!F\GH _\?[9!%R5B:XX%EZ,>R:,<])B.0?N0#&X!0
MF0TV>Y!X7(P 2A@&/7I#L2;CA] $B>4&"(&.B-W#';U8@H\FR1!#1U,6\5#*
M/NC1BSEG:%E!&E4'_D",B/6C0OW01SQV8>H,57$O?T*I?2DL9AY&,"3]<+)V
M/.!#?3YDBQFB44)^L")W:&1<NO3(!!^D[(;T8YO:2<)"Q%G(&@\ D7OY8GV)
M.1TI^#J9(IGCK0MB;$IY")]]/I@[-;(+#]5P(X;,T;\B@NPC$]"*%*T5.</]
M91#;):3WZF%%_-$.750!D!54I4#:3:UW*P3B#TK"OB?BK:VQ8J\-P26>)@*/
M9QJ$V^G_&KA>;JAK<M<%!R /29GW"8]::\< 2MA%-E,I1$EQN9\* 0:+>0#N
MANBC"A4T " :;&?M\($/2>  ENG9 1TXX8D 'WE%U\67?@BAX,FMBS="J?"$
M?#1#$F>WR0U"\88 _5/$P#;:*9(/0BB*S@B)AX>40 QWZ(/+$$$Y0S"I2:BX
M"^P%G@6QRFZ0?.S=F7-ONK1^;O&-),M#+;+(%:M=D+/?/,,>$?PE50Z5?;C
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M> E"!.[7D-OC#]PP!P0Y6@99D0AI<&(&B!KI.OY@#I$05988DM<5@BY7%Q+
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M9_[F!50/92!:BM,(D&CG([4/<L"20E$*!^[GV%.*@APU"75NZ 5D#Z;X$Y'
1#6[.Z$48":=0#H4.( $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>jnjlogorgb4a08.jpg
<TEXT>
begin 644 jnjlogorgb4a08.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X1Q217AI9@  34T *@    @ " $2  ,
M   !  $   $:  4    !   (>@$;  4    !   (@@$H  ,    !  (   $Q
M  (    N   (B@$R  (    4   (N(=I  0    !   (S.H<  <   @,
M;@  $1 <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                       6XV
M "<0 !;C8   )Q!-:6-R;W-O9G0@5VEN9&]W<R!0:&]T;R!6:65W97(@-BXQ
M+C<V,# N,38S.#4 ,C Q-3HP-#HP-R Q-SHP.3HT-0  !* !  ,    !  $
M * "  0    !   !$* #  0    !   #=NH<  <   @,   ) @     <Z@
M  @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                              8! P #     0 &
M   !&@ %     0  $5X!&P %     0  $68!*  #     0 "   " 0 $
M 0  $6X" @ $     0  "MP         2     $   !(     ?_8_]L 0P (
M!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N)R B+",<'"@W
M*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<(3(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R_\
M$0@ ,0"@ P$A  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'
M" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R
M@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*
M4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2E
MIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S
M]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41
M  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC
M,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:
M8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:
M  P# 0 "$0,1 #\ ]_HH ** "B@ HH ** "B@ HH ** "B@ HH *@O+R"PM7
MN;A]D28R0"223@  <DDD  <DD"DW97*A!SDHQW93T?5SJPO,V_E&VN3;D"0/
MR$5CG' (+%2 2 5/)J]<W$5I:S7,[A(84,DCG^%0,D_E24KJYK5H.%7V2U>G
MXE#0=;CUZR>YB@EA"LHVR$$D,BR*>">JNOT.1VS6I1&7,KBQ%%T:CIMWL%%4
M8A10!!>7D%A:O<W+[(DQDX))).  !R220 !R2<54T?5CJHO<P"$VUP8"!('Y
M"*QR1P&!8J0"0"IY-2Y:V-XT'*E*KT7X[?YEZXN(K2VEN)W"0Q(7D<]%4#)/
MY5GZ#KD6O63W,4$L 5E&V7&2&19%/!/577CL<CWH<DI)!##RE1E6Z*W]?+0U
M**HP"B@ HH *Y7Q3\_B3PK'<[1IYO79RW \\1GR1GUSNP.]14^'[OS.S ?Q_
M.TK>O*[?C8YW0/&,VEZ#>Q7%E]IU==6DA:V1P@WR.#EFY"Y9F ').TXX#$:O
MB#Q)</I_B#2+G29TF6RF,31G<'BVN#(2P50 -A(#,?G Z@@81JODM8]JKED/
MK7M%.UY72?9./7T>R3>GGIG^$O$,>DQZ+ICQI+!?6QEGU%I0BH\<"L4V],)&
M(E+9 )!SR&JVWQ&D6+6!_8LBW5CM>.W>8!WB*EB[C'R84 D<\LJ]31&MRQ2M
M_5K_ (A7RCV]>4^>R=G:VRYN5KSY4M>Y<D\?VL-SI*R6DY2^M5D;R4,FR9U5
MHXLC'S$$\8_B0\ DU#_PG5\(KN[/A]_L%G=2VUPZ3EY(O+7<Q9%0CH<?>VY!
MRP&&JO;]D<\<D5DZE1*^WK=I7U5KZ?>.G\?O9RZS%>Z/+#-I\:O% )E=YMP+
M#..%PHW'!; #'G%;>G>([*Y\.V.KWTT%A'=("!/,%4,<_*&.,]#51K)NST,,
M3E4J5-3IRY^9I)).[O'FO;?R^1S^J:S9:[K/AMX94DTN+598I7/3[2B'R<$=
M02<C'!R*S=#\7MI&B:FLMG]IU1=7EB-NCA,L[CEF/ R2P Y)VG PK$9NHE+F
M7]:(]"&7RG06'D^5JU_+WI)_ARZ&IX@\27+:?K^D76D3I,+*<PM$2RR1[7!D
M)8*H &PD!F/[P#J"!G^$O$46DQZ+ICHDL-[;&6XU%I0BQO' K;-O3"1")2V0
M#R>H:AU/?3:\OQ)A@$\'*$)7O[R:ZI1O:W=M=[Z:KH7I/B%,B:RIT61;FQ"2
M10/-AI(F4OO<8^3" $@YY8+U-6)/']I!<Z0DMM,4O[59'$*&4QS.JM'%D8RQ
M!/&,\H> <U7UCNOZN8O(W>T)I]>RMRIIW\V[?B1'QU?".[NSH#FPL[J6WN'2
M<O)$8UW,614(Z''!VY!RP&&I9_'[V=QK,%YHTL,UA$LD<(G5WFR"0#C@87YC
M@M@!CSBCV[6Z!9)"3Y85;OT\TGUV2:=^WSMT7A[6!KV@6>IB$P_:$),>[.T@
MD'GZBM.MHOFBF>-B*7L:TZ5[\K:^YV"L/Q;!!<>'Y4EC+3&2-;1E;:T=PS!8
MG#=5PS#D=L]>A)_"RL))QKP<>Z_,YW1O"\>IZ%XCT74;MIG;5GD:ZC15;?MC
M?<!@@')P0.Q(K;C\+S2:=J":AJKWNH7MFUFUV\"((T.[ 5%Q_?R>><#VQC&E
M=7N>IB<R49."AU36KNDU%M?.RU]>Y'-X'T^5]!C#8L])21! 4'[_ '  EB,#
MD@EAC#9.>":=-X-M)I_$-R9C]HUB+R?,* ^0NP+@=S\WS'D9PH[9->Q7]>EC
M%9O5TNNGYSYV_GMU*I^']F)M 9+N4)I+^805!:=QMP2W;[BC'/R@ 8Q3YO!(
M?4[UX-6NH-*U"3S;W3TZ3.?O8?.4#<;@.HR,XP O8+H_ZM8U_MJ;^*">C^_F
MYD_D^FS5UL]+$_@RQNM?U35;B:5S?VOV8QX&(\KL9E..NW@>F6ZYXCTGP/8V
M6CP65]/-?2PR"2.XWM"T>T$*$*$%0 3QGJS'O3]BKW]3)YO5]DJ:25N5)[Z1
M5MGIK_FNI7U/PMI.E>']0CMH9B]Q<));$SL6AN6*I&ZN22IWD$MUY.<C JII
M'A6/4-$\1Z)J-XUPTFJM(]U&BHV\I%)N Y .3@X]Q4.DN:RV_P"'.FGF55T7
M5DKR4DUTVY=-.CW^_N;$?A>:33[]-0U5[W4+RS:S-V\"((T.[A57&/O9//.T
M>@Q%+X'T^1M"C#$6>DI(H@*_Z_> #O(P.2"6&,-D@\&K]BFM7_5[G,LUE"3]
MG&T=;*[T]UQ6_:[?F^Q+<^$+:YN?$%T9B+G5X!!YA0'R$$87 [G)&3R,X [9
M-(_#^S$V@,MY*$TA_,(V@M.XV8);MC8HQS\H &,4G03_ *\[E4\XJ4TER[*W
MW0Y%_FUU?WDDW@@/J=Z\&K74&E:A)YM]IZ=)G/WL/G*!OX@.HR,XP!8N/!=A
M=Z_J>JW$LCM?6GV8QX'[O*[&93CKMP!Z9;KG ?L5U8O[7FM802?+9ON_=N_F
MHI6VW?4G\*^&T\,:4+/[6]W(3S*Z[<+V51SA1DG&3RS'O6[6D(\L5$X,7B'B
M:\JS5N9WL%8GB?2;W5;&U.G30QWEG=QW40G!\MRN1M;'.,$].X'3K1--Q:08
M6K"E6C.:NNMM[=;>9?TNP_LZP6W,OFR%WEDDV[=[NQ=B!V&YC@<X''-7*:5E
M8RJS]I.4^[N%%,@** "B@#$\3Z5>ZK8VITZ:&.\M+N.ZB$X/EN5R-K8YQ@GI
MW Z=:O:5IXTRQ$!D\V1G>663:%WR.Q9CCL,DX'.!@9-0HOGYCLEB(O"QHI:I
MZOI;I^;OZ(NT59QA10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 4
M4 %% !10 44 %% !10 44 %% !10 44 ?__9_^TI%%!H;W1O<VAO<" S+C
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M8714:6-K970\+W-T<FEN9SX*/"]D:6-T/@H\+W!L:7-T/@HX0DE- ^T
M !  E@    $  0"6     0 !.$))300F       .             #^    X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-! H       $  #A"24TG$       "@ !          $X
M0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M  $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M     '   /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z   .$))300        "  $X0DE-
M! (       0     .$))300P       " 0$X0DE-!"T       8  0    ,X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #20    8              1    -V    "@!5 &X = !I '0
M; !E &0 +0 Q     0                         !              -V
M   !$                      !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   !$     !29VAT;&]N9P   W8    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   1      4F=H=&QO
M;F<   -V     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     3_P        .$))3004       $    !#A"24T$#
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M/K]6;L]3:#Z3=H]K/W]UK?4L_?\ T?\ QB/#E H'^7#_ -^MEF^'SGQSB29
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MVH;5_._S?J>GL],S_JYB6]6RNJ6O+GY6/]G:R!^C!'IVV5N.[WO9M_J?I/\
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MI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V0 X0DE-!"$      %4
M   ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$
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M0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M      $  /;6  $     TRU(4" @
M                               18W!R=    5     S9&5S8P   80
M  !L=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@
M BP    48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E
M9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D
M=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P
M  @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D
M($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M       2<U)'0B!)14,V,3DV-BTR+C$
M                                     %A96B        #S40 !
M 1;,6%E:(                     !865H@        ;Z(  #CU   #D%A9
M6B        !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@
M                    9&5S8P         N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                     &1E<V,         +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N
M8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                      !V:65W       3I/X %%\N !#/%  #[<P !!,+
M  -<G@    %865H@      !,"58 4    %<?YVUE87,          0
M                  */     G-I9R      0U)4(&-U<G8        $
M  4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _?RBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBO,OVO_P!IS1?V/_V>/$GC_6PLL.BVY^RVN[:U_=.=L,"^F]R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"OR/NZOA3Q?3Q=' 3RZK[:K%SC#E][E32<G'>*3:3<K:NQ]0T5\Z?LA?\
M!4OX._MK:J-)\)Z[<6'B1D:1=$UB 6E]*JC),>&:.7 !)$;L0 20 ,U]%UV8
M?$TJ\/:49*2[H^5SS(,RR?%/ YK0G1JK7EG%Q=GL]=T^C6CZ,*_FM_X*4?\
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MW/X0ROPZXFS'*YYU@<#4GAH)MS4=+1^)KK)+6[BG:SOL?:]%%%=Q\6%%>/\
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M_@O+^SW\'[R:TL-9UKQQ>0C#+X?L/,A#9Z>=,T4;#OE&88]3Q75_L@_\%8/
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MP?(1D(!_CE1A@I7S7_P5/N]4\1?\%)?BDFOSR03'Q ;9))LD0VJJB0-C/W1
M(R!Z>E?L7_P18^']O\/_ /@FW\.4AC1)]8BN=5N77K*\US*5)]Q&(U^B"O/_
M /@JK_P1TL_VX-57QOX,U"Q\/?$2&!8+K[6&%GKD:+B,2LH)CE0 *) K94!6
M& K+[5?(9RR>E'#J\M)M=[K\U>Q^/9)XWX+"^+.8XG/JCAA[3PU.=KJDJ<U9
MVUM&<HN4G9^\TW:*T^#O^"@G_!&'4/V2O@Q8_$KP/XM'Q \&+'"^HSK;+%-9
MK)M$=RA1V62!F8<@@IN7[P)9?N?_ ((6?M_ZC^U1\$]2\%^,-0>^\9> 5CVW
MD[[IM3T]\K'(Y)RTD;*4=CU!B))9F)_._4_^"</[87PFTZ]\*V7AOQZNB74<
ML$UKHVN";3KN*12KJR13;"KJQ!5@"0Q!'45\Z?"CX1>+?B7\8+3P!X=MIE\4
M:[=-I LFN%MO,D#?-%(S$* "G(8XROTKR*..G@<9&M0H2@I:.#OJ_)M7W\G^
M)^J9OP7@N-^$:V5YQG-#%U*$O:0Q4%#FIPW;J1A/EUBI)M2BFK-^]"[_ *!_
MVF/^"IGP0_97T^Y&N^-M.U;5X =NC:'(NH7SL/X"J'9$?^NK(/>OPL_;_P#V
MKX?VU_VI_$/Q#MM&ET"TU5+>""SDN!/(D<,*1!G8 #<VS<0!@9QDXR?LWX!_
M\&U_C37;R"Y^)/C?0_#U@<,]GHB/?7C#NA=U2.-O<>8/Z?*7_!4K]FSPQ^R1
M^V+K?@/PA'>IHFCV%@8VO+@SSS/):QO)([8 W,S$X4*HSP .*Z>(,1F5?#JI
MB8*%.ZLNK=G_ ,'MZ'@^ V1>'>2Y_4P/#F,GC<<Z4G.I9JG&"E"\8VM'67*]
M'-Z/WEL^K_X(I?!;PW\<_P!OWPWIOBG38M7TW2[6XU:.UFYADG@4-$9%_C4-
MAMIX) !!&0?Z"+^_M])L)[JZGAMK:VC:6::5PB1(HRS,QX  &23TK\(O^#??
M_E(MIO\ V M0_P#0%K[/_P"#@/\ ;I?X+_!NU^$OAV\\KQ'X]@,NK21N1)9:
M6&*E>.AG=63O\D<H(^8&O2X<Q=+!Y54Q,ULWZMV5D?G?T@.%\RXL\4,%P[A)
M.TJ4-[N-.+E-U)VV5HJ[VYFDM['YX_\ !5G]O:[_ &Z/VDKR\L+JX7P+X:9[
M#P[;,2JO&#\]VRGH\S#=R 0@C4\J2?F*OT&U;]@"R_9Z_P"")_B;XB>(]*MV
M\=>.;K2KVVEGA!GTG3VNXO)B0L,HTJL9'VX)#HI^[7Y\U\?FE.NJJJXE^]47
M-Z7O9?<OD?UOX8YCDE7*ZF6\/1MA\%4EAT]/>=.,'*5UO>4G>7VFG+J?TI?\
M$V_%]UXZ_8*^$FI7DDDMT_AFS@DD=MS2&*,1;B>Y(3/KS^->URRK#&SNRJBC
M)).  .]?/W_!*/\ Y1T_"/\ [ 2?^AO7@G_!>/\ ;X'[/'P-'PS\.7FSQC\0
M;9TO&C;#Z;I9RDC>S3',:_[(E/!"Y_4UCH8;+HXBKTBOF[+3YL_S#?!F+XCX
M^Q&099&SGB*L;VTA!3ES2?E&*OYVLM6C\\?^"PO[=K_MI_M/W4.CWCS>!/!;
M2:;H:ACY=VV[$]YC_IJRC:>#Y:1Y .:^3*^^?A-_P3ET[P-_P2"^)?QF\8Z3
M'-XE\165K/X96X0[M+LA>0 7"#^%Y\D@_P#/+;CB1@?@:ORS-*>(]HJ^)^*H
MN;T3;2_!:>1_IWX98W(UEU7).'U^YP$_J[>EI3C&,IR36[YI/F>EY*36C3/Z
M)?\ @CAXPN_'/_!-+X4WMX[/-#87.GJ6;<?+M;VXMHQTZ!(E '8#'/6L7_@L
M%^WM_P ,1_LTRQZ+=)'X\\9^9IVA@'Y[-<#SKS'_ $R5@%_Z:21\$!JK_P#!
M%W7[+PG_ ,$F_A[JNIW4-CIVF6^LW5U<S-MC@BCU2^9W8]E5023Z"OS@:77/
M^"X/_!494+:A:>"+>0D#^+2="MGY/HDLS,/7$MP.JK7WN*S&I2RVA1HZU:L8
MI?-*[_KU/X8X;X"P.9^(>=YMG"4<MRZO7J5;[/EJS<*=NM[7:ZQ3CO)'P[<7
M$EW/)++(\LLK%W=R69R3DDD]237VG_P0"\3WFA?\%&]#M+:4I!K6CZC9W:\X
MDC6 S@?]_(4/X5Y?_P %7?!>D_#K_@H'\1M"T+3K32='TJXM+>TL[:,1Q01K
M8V^%4#_)/UKT'_@@S_RDM\'?]>&I_P#I%+7P^74G1S2G2OK&:7W.Q_:?'N94
MLW\-,;F486C6P<JBB];<U+G2?2ZNMNJ/WZKP#_@I?^U_!^Q5^R1XC\5PSQ)X
MBO$_LO0(FP3)?3*0C8/41*'E([B(CJ17O]?A'_P5:_:>UG_@I%^W-I7P^\!*
M^KZ'X?O3X?\ #\$+#R]1O'<+<76>FQF4*&)VB.$/QN:OTK/\R^J89\GQRTCW
MN^OR_.Q_G5X'>'T>*>(X+&)+!X9>UKR>D>2.JBV]/?:L]5[JD^A\E?!7XWZ]
M\"_C=H'C[1[J1M>T#44U)))'9C<,&RZ2'J5D4LK>H=O6OZ8?@)\:]$_:-^#7
MASQQX=G$^C^);)+R#/WHB>'B;T='#(P[,IK^8#QCX1U+X?\ BW4]"UFTFL-6
MT:ZDLKRVE&'@FC8HZ'W# BOIW]D;_@K=X_\ V-_V6?%'PY\-06TMUJMZ+K1M
M5N&WG0/,4BXV1$$.6*HR D*C%V(?=BO@^&\Z6 J3A7ORO[[K_/;[C^V_I!>#
MU;C? X3&Y(HO$TI**;:494IM7;?:#M-6O[KG9-M(_7K]OG_@J3\._P!@K1GM
M=4F/B+QK<1>99^'+&91.01E9)WY$$1X^8@L>JHV#C\>_VG/VN?V@?^"B^A^(
MO$VJKJJ?#OPR@GN[/35:TT#2UW (LCLP668LP"B1GD9FP@&0H^A?^";O_!&W
MQ#^UYK$?Q:^.ESK">'M:E_M"WL+FX<:EXFW'=Y\TA.^*!NQXD<<J44J[=[_P
M<-^/].^"GP1^&7P8\'V-EX?\/WDLVJW.GV$*V\"0V^U($VJ "K222N1W:-6.
M3S7K9G4QN+PD\7B&Z=)?#%;ROHK^7Z=.I^8>'& X1X6XHPG"N04XX_,Y2_?8
MF?\ #HJ"<IJDM?>2BUHTU)I2F]8+\G;"PGU6^@M;6&2XN;J18HHD4L\CL<!0
M!U)) Q[U^T'Q[_8TB_8#_P""'OC_ $'0H GC+5-.L)O%&H6^#+>RR7MLES'N
M'6&.&26-1TV;FQEV)_-?_@EIX$M?B/\ \%"OA+IEZJO;)KT=^RGE7-LK7*J1
MW!:$ CH0:_HM\=^!M*^)W@K5O#FO646I:+KEI+8WMK+G9/#(I1U..1D$\C!'
M48-8\*Y9&MAZ]7[33@GVNM7^*/7^D[XC5<GS[)LM2;HTIPQ-6*_Y>*%1<D7T
M:7)/1Z7:?1'\^7_!+[]@C0?^"@7Q,\2>&=6\;_\ "(7NEZ6+W3XH[5;B:^<N
M%9@K,H*1C!8 [CO7& ":LM:_%#_@BO\ MRVPFE$ESII25_(D9;'Q/I<C<KS_
M  L%(P03'(F>2@)]P_:>_P""!/Q=^"GQ"EUSX,WO_"6:-!.;C3Q%J*:=K6F@
M'(!9V1'*C@/&X9L9V+G%?.O[8O[,W[2W@KPA8>*_C;:^-KO2K*<:=9WVOZ\N
MI_9WD!81)F:1E#>63P /EY[5Y-;!UL)25Z,HU8._.KM->?33HU\S]2RKBS*>
M*,TE*EG&'Q&78NFH/"5.2-6,FK>ZKJ;YM>:,EHW>+T1^JO[5?_!=GX2?!#X8
M:?>^$;N/QYXLU[38K^STNTD AL/-C#H+V49$;+GYHES(",$)D-7Y3?$V/]H'
M_@I9JGB;XI:CHOB'Q;IWAVWEFN;JVMS%IFCV\8+M!;JQ"X1?F*)ND/WFW$EC
M[E_P1K_X)5>%OVX=,U3QQXUUF\?P]X;U;^SFT&S4Q2:@XBCEW23YRL1$FTJ@
M#G!^9>,_L)\0/ FB_#']EWQ)X?\ #NEV6BZ)I7AR]@M+*SA$,-N@MY.%4<#)
M))/4DDGDU]%#"8W.*7M\7+DIVNE'KYO_ (/R2/P#%<4<(>$^:/)>%\,\5F#F
MHU:U:]J<9-/DC9+6S7PV6SE*;7*OY@J_;?\ X-O/%USK7[%'B72[B262+1?%
MMPMMN;(CCDM;9]@'8;_,;ZN:_$BOVB_X-IO^34_'G_8V'_TCMZ\/A*368Q7D
MS]L^E52C/@"M*2NXU*37D^:WY-KYGU!_P4C_ &U++]A?]F'5O%9,,_B*]_XE
MWA^TDY%Q>NK;69>\<8!D;ID+MR"PK^<SQ9XJU+QUXFU#6M9OKG4]6U6X>ZO+
MNX<O+<2NQ9G8GJ2237VQ_P %&?C;KW_!5#_@HSI/P[\$RB[T32;]O#>@ -N@
M=M^;N_./X#L+$C_EE AZYS@_\%L_V;_"_P"RA^T#\._!/A*P@L].TOX?V(EE
M6)4EU"?[=?K)<S$#YI7V@DGL !@  ;\18FICI3K0?[JDU%>;>[_KI;N>'X!\
M/Y?P71P>3XR/_"EF,)5IKK3I07N1?5;[=9\]_@1Y!_P3@\67O@O]OKX.7FGS
M-#/-XNTZP9E)!,5S<);RKQV:.5U^AK^E:OYE_P!@O_D^;X+_ /8]Z'_Z<(*_
MIHKV>")/ZO47FOR/Q_Z9E.*SS+JB6KI23?DIZ+Y7?WA116%X]^)WAKX5Z/\
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M7.U0?O.QPJKU9F ')%?DM_P;,_\ )<_B=_V K;_TH-:__!P=^VW<^./&NF?
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MY5%DV)G'+R,>HQ^V?_!.?]B72_V$_P!FW3/"D @NO$%[B_\ $%^B\WEXRC<
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M^#EUXWB\9:1X4TE;Z2PM(Y;-[R:Y>,*78A64(N6 '))P> ,$VOBG^SK^TO\
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M6+26T[?P1M(Q=7/"L[[B%P1^NMEXYT34?#(UNVUC2KC1BGF"_CNXVMBO][S
M=N.>N:^XR?,Z6+PT9Q>J6J[/K\NQ_%?BOX=YEPKQ#B,%B*4O92G)TIV?+.$G
M>-GMS).TH[II]+-\K^U;XIM?!'[,'Q&UF]=8[73/#.HW,FXXR%M9#COR3P!C
M))'6OQA_X-[M.GO?^"A]K+%&7CM/#VH2S$$?(I$:9_[Z=1^->\_\%O?^"KGA
M?Q[\.+KX.?#+6+77TU.5/^$DUBSD$EHL4;AUM89!Q(6=5+NI*A5VY8LVV_\
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M2_A%\%O@3X4FEO+?1O#.BWFM1VA+M>:A)91"WM<+]XQHX8KSEY5X#1U^I/\
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M^A#+<PX5QV0X?$.K'#TYX6I-OWN>%%*3;5KR2DG)K[5S^HBOY\_^"Y<4T?\
MP5 ^)+2+(J2)I30ELX*_V7:#(]MP;\<U_097XQ_\'(OP!N?"_P"T+X2^(UO;
MO_97BK2AI=S*%RJWELS$;CV+0R1@ ]?)?K@X_0.,:,IX#FC]F2;_ !7ZG\)_
M1+S:A@^.71K.SKT:E./^+FA4M]U-GGW_  ;V_$.U\#_\%"(=/N9(XW\6>';[
M2(-W&Z0-#=@#W(M6^O3N*_=VOY7/A?\ $G5_@[\1M#\5Z!<FSUKP[>Q7]E-C
M(26-@RY'=21@CH02.]?T)_L+?\%-_AO^VWX#T^6QUG3M#\9F)1J/AR\N5BNH
M)@/F,(;'G1$\ATSP0&"ME1Y_!V94E2>$F[23NO-/]4?=_2W\/<QEFE+BG!TG
M.C*"A4<4WR2BW:4K;1E%I)[)QLVKJ_TA7Y,?\'.GBB*74/@WHL<X,T,>K7L\
M/'"N;-(F]>J2C\#7Z2?M!_M4> /V6O"%SK7CKQ3I.A6]O$94@FG4W=WC^&&$
M'?*Q[!0?? !-?S^?MO\ [4_B#_@HY^UY-X@M-,NU.JRP:'X;T<,))88-^V"'
MC@R222,[8.-\K < 5V\6YA3AA'A4[SFUIU233O\ A;S/C_HL<#YAB>**?$M6
MFX87"QFW.2M&4I0E!13>]E)R;6D;*[5U?]BO^"%NCS:3_P $R_ ,DP*_;I]2
MN$7!!"_VA<*,Y]=N>.Q%=%_P6/\ ^4:7Q6_Z\+;_ -+;>O6?V5?@G%^SE^SA
MX(\"QNDK^&-'M[*>1?NS3J@\Z0>S2%V_&O)O^"Q__*-+XK?]>%M_Z6V]>I.B
MZ.5.E+>--K[HGYK@,XI9KXH4LSH?!6Q\9Q_PRQ":_!H_G9K[N^+/[:"?#7_@
MBM\'_A!HMV4USQL-3O=7\ML-;Z:FM7VU#W!FE3'NL4@/#"OA&OI#_@E7^Q_)
M^VE^U_X>T&_MWN/"N@_\3C7BP)C-I$X(@_[;2,D> 0=KNP^Z:_+,MJ5O:.C0
M^*HN3TNU?\$?Z<>(N RF6 HYQG4K4<OJ?66OYI4Z=2,5ZJ4U**ZR274_5#_@
MA1^Q>O[-?[*</B_5K0Q>+?B6L>I3;UP]K8 $VL//3<K&4^IE4'[@K\S_ /@N
M'_RE%^)__<*_]-%E7]!L42PQJB*JHHP !@ #M7\^7_!</_E*+\3_ /N%?^FB
MRK[/B?"0PN54J%/:,E^4KOYG\?\ T;.*<7Q'XFYEG>.?OUL/4E;?E7M:"C%>
M48I17D@_X(>?\I1?AA_W%?\ TT7M?T">(/$%AX5T6YU+5;ZSTS3K)#)<75U,
ML,,"CJS.Q"J!ZDXK^=__ () _$CP_P#"+_@HG\//$7BG6=.\/Z%IW]I&ZO[^
M=8+>#?IEW&NYV.!N=U4>I8#O7L/_  5._P""DNM_\%$OB[IOPL^&*W\_@9=2
MBM+&")"D_BB^9]D<C+U\H,0(T(')WMAMJIQ9!F]+ Y;)RUFYNT>KTC^!];XY
M>%69<:>(>%I4;TL-#"P=6LU[D$JM9M7T3FUM&^VKM%-G[?Z)KECXFTFWU#3;
MRUU"PNT$D%S;2K-#,AZ,KJ2&!]0<5<KRC]A[]G ?LC_LH^"?AXUX;^X\/63"
MZGR2LES-*\\^SI\@EE<+GG:%KU>OT&A*<J<935FTKKL^J/X-S;#X:ACJU#!5
M/:4HSDH3M;FBFU&5M;<RL[7TO8****U//"BBB@ HHHH **** "BBB@ HHHH
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M]>\,_2RP>4\(X?*U@YSQE"G&G%MQ]D^2*C&4GS<^R3E%1U=TI*]US7_!//\
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M_"?_ ,)'3_\ XU7K%%8SP]*;O.*?JD>IA,[S'"P]GAL1.$>T9R2^Y-'Y(?\
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MG;KR54<EF/\ $[,2S,>69B3R:W["P@TJRAMK6"&VM[=!'%%$@2.-0,!5 X
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M<$9'8XXKYXUK_@C%^S+KVJB]G^%>GQS [MMMJNH6T.<Y_P!7'.J8]MN*_/\
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M0Y1/).'*-2C"LK5)U.52<>L(J,I)*6TI.6L;JVMQ:***^U/X["BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*G!J4V^UTN57^TTNIXM_P;H_ !_B!^UQK/CNYMB^G^ -*<02D<)>W8:% /\
MM@+GZ9'J*_;BOE7_ ((Z?LD2_LD?L5Z':ZI;?9_$WB]_^$@U=67$D+RHHB@;
M/(,<*H"O9S)ZDGZJKGX=P+PN!A"2M)ZOU?\ P+(]SQ\XTAQ+QIBL70ES4:5J
M5-]'&%TVO*4W*2\F@HHHKW#\:"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP/_X+W?"6
MZ^'/_!1#7]7>%TL/&NGV6KVKX.QML*VT@!]?,MV8CMO'8BOWPKP7]O?_ ()\
M>"_^"@/PYL]'\2R76EZMHTCRZ3K-FJM<6#. '4JW#Q/M7<AQG:I!4@&O#X@R
MR6-PCIT_B337^7W,_9_ ?Q%PW!O%,<QQZ?L*D)4ZC2NXQDXR4DNMI1C>VO+>
MUWH_QN_9!_X+/?%[]C?X2CP5HT?AKQ#H5IO.FQZW;332:9N8L5C:.6,F/<6;
M:V<$\$#BM']DG]GKXD?\%E/VQ)O$7C?4=1OM"M)HYO$NL[!'%:6RDE+*W  5
M'<95%4?*"SD'!W?6W@'_ (-E/#FD^)X;CQ/\6-7UO2(V#26>GZ$FG32#/W?.
M>>8 'V3/TK]%/@5\!?"7[-7PWL?"/@G1+70=!T_)CMX<LTCG&Z21V):21L#+
ML23@<\"OG,NX?Q]9PAF$FJ<-HWO>WI=6^?DC^@N/O';@?*8XG&< T(RS#%)J
M5=4Y0Y.;XI>_&,G-O6RCRN7O2;:L^B\.^'['PEX?L-)TNT@L-,TNWCM+2VA0
M)';PQJ$2-0.BJH  [ 5>HHK[Y*RLC^&)SE.3G)W;U;?5A1113)"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
